Soleus Capital Management, L.P. Portfolio Holdings

Soleus Capital Management, L.P.

  • $1.18 Billion
  • Q3 2024

Soleus Capital Management, L.P. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.18 Billion distributed in 87 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Iovance Biotherapeutics, Inc. with a value of $80.1M, Tg Therapeutics, Inc. with a value of $59.3M, Terns Pharmaceuticals, Inc. with a value of $51.9M, Axogen, Inc. with a value of $42.1M, and Grifols Sa with a value of $40.2M.

Examining the 13F form we can see an increase of $190M in the current position value, from $987M to 1.18B.

Soleus Capital Management, L.P. is based out at Greenwich, CT

Below you can find more details about Soleus Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.18 Billion
Healthcare: $1.09 Billion
ETFs: $88.9 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 87
  • Current Value $1.18 Billion
  • Prior Value $987 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 16 stocks
  • Additional Purchases 24 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 36 stocks
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email